New world cutaneous leishmaniasis in returned travellers: Treatment failures using intravenous sodium stibogluconate

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 4, 2003, Pages 443-445

  Lawn, Steve D ^a,c   Yardley, V ^b   Vega Lopez, F ^a   Watson, J ^a   Lockwood, D N ^a  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cutaneous leishmainasis; Drug resistance; Leishmania (Viannia) spp.; Sodium stibogluconate; Travel medicine; Treatment failure

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; STIBOGLUCONATE SODIUM;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONCENTRATION RESPONSE; DRUG SENSITIVITY; DRUG TOLERABILITY; FEMALE; HUMAN; IN VITRO STUDY; LEISHMANIA; MALE; NONHUMAN; PARASITE ISOLATION; POLYMERASE CHAIN REACTION; RELAPSE; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN LEISHMANIASIS; SUBSPECIES; TRAVEL; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LEISHMANIASIS, CUTANEOUS; MALE; PARASITIC SENSITIVITY TESTS; RETROSPECTIVE STUDIES; TRAVEL; TREATMENT FAILURE;

PROTOZOA; VIANNIA;

EID: 19244366181     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)90084-8     Document Type: Article

References (17)

1. Aronson N.E. Wortmann G.W. Johnson S.C. Jackson J.E. Gasser R.A. Jr. Magill A.J. Endy T.P. Coyne P.E. Grogl M. Benson P.M. Beard J.S. Tally J.D. Gambel J.M. Kreutzer R.D. Oster C.N. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience Clinical Infectious Diseases 27 1998 1457-1464
2. Ballou W.R. McClain J.B. Gordon D.M. Shanks G.D. Andujar J. Berman J.D. Chulay J.D. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis Lancet ii 1987 13-16
3. Berman J.D. Chulay J.D. Hendricks L.D. Oster C.N. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro American Journal of Tropical Medicine and Hygiene 31 1982 459-465
4. Chulay J.D. Spencer H.C. Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate) American Journal of Tropical Medicine and Hygiene 34 1985 702-709
5. Cox F.E.G. Classification of the parasitic protozoa In: Cox F.E.G. Kreier J.P. Wakelin D. (Eds.) Topley & Wilson's Micobiology and Micobial infections 9th edition 1998 149-155 Arnold London
6. Croft S.L. Yardley V. Kendrick H. Field epidemiology. Drug sensitivity of Leishmania species: some unresolved problems Transactions of the Royal Society of Tropical Medicine and Hygiene 96 supplement 1 2002 S1/127-S1/129
7. De Bruijin M.H.L. Barker D.C. Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA Acta Tropica 52 1992 45-58
8. Grogl M. Oduola A.M. Cordero L.D. Kyle D.E. Leishmania spp.: development of pentostamresistant clones in vitro by discontinuous drug exposure Experimental Parasitology 69 1989 78-90
9. Grogl M. Thomason T.N. Franke E.D. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease American Journal of Tropical Medicine and Hygiene 47 1992 117-126
10. Guderian R.H. Chico M.E. Rogers M.D. Pattishall K.M. Grogl M. Berman J.D. Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis American Journal of Tropical Medicine and Hygiene 45 1991 92-97
11. Hepburn N.C. Tidman M.J. Hunter J.A.A. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis Transactions of the Royal Society of Tropical Medicine and Hygiene 88 1994 700-703
12. Herwaldt B.L. Leishmaniasis Lancet 354 1999 1191-1199
13. Herwaldt B.L. Berman J.D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies American Journal of Tropical Medicine and Hygiene 46 1992 296-306
14. Jackson J.E. Tally J.D. Ellis W.Y. Mebrahtu Y.B. Lawyer P.G. Were J.B. Reed S.G. Panisko D.M. Limmer B.L. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy American Journal of Tropical Medicine and Hygiene 43 1990 464-480
15. Lainson R. Shaw J.J. New World leishmaniasis-the neotropical Leishmania species In: Cox F.E.G. Kreier J.P. Wakelin D. (Eds.) Topley & Wilson's Micobiology and Micobial Infections 9th edition 1998 241-263 Arnold London
16. Navin T.R. Arana B.A. Arana F.E. Berman J.D. Chajon J.F. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala Journal of Infectious Diseases 165 1992 528-534
17. Wortmann G. Miller R.S. Oster C. Jackson J. Aronson N. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel Clinical Infectious Diseases 35 2002 261-267